FDA approves Ozempic for kidney disease
Clinical trials showed Ozempic slowed kidney disease progression and lowered risks of kidney failure and cardiovascular events.
Clinical trials showed Ozempic slowed kidney disease progression and lowered risks of kidney failure and cardiovascular events.
Company raises fiscal year 2025 outlook.
According to Advocate, all 47 clinics inside Illinois Walgreens were staffed by one to two medical office assistants, along with "additional clinicians who support virtual care operations."
Free grocery delivery and a stipend for healthy youth activities help members save time and money this year,
Sirolimus oral solution is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged greater or equal to 13 years, receiving renal transplants.
Blended, patient-level datasets leveraging proprietary tokenization technology simplify data enrichment while adhering to privacy standards.
“NACDS thanks Congressman Krishnamoorthi for his consistent leadership on this issue of importance in his District, throughout Illinois, and across the nation."
“An anti-science conspiracist, Robert F. Kennedy Jr. shouldn’t be allowed in the building at the Department of Health and Human Services (HHS), let alone be placed in charge of the nation’s public health agency."
Drug price inflation driven by specialty medications.
Marking PTCB's 30th anniversary with a significant milestone: more than 300,000 active Certified Pharmacy Technicians.
If CMS and the new administration want to save the program, and if they want to prevent the disappearance of many more pharmacies, they will make a number of changes, said NCPA.
Four new members from diverse health care professions, organizations and industries join board.
Louis & Clark Pharmacy professionals earn official certification as dementia practitioners.
Noel will take charge at UnitedHealthcare, the largest U.S. health insurer that provides benefits to more than 50 million Americans, at a critical moment.
The pages included draft guidance on clinical trial diversity, a discussion paper about diversity in clinical trials from the Center for Devices and Radiological Health and the equity initiative at the Oncology Center of Excellence, which is responsible for cancer medicines.
The deal was negotiated by 15 states, including New York, California, Connecticut, Oregon, Texas, Florida and West Virginia.